Skip to Main Content

Paper Details

Outcomes of patients with IDH1-mutant relapsed or refractory acute myeloid leukemia receiving ivosidenib who proceeded to hematopoietic stem cell transplant.
Leukemia
9
2021
Author NameAffiliation
Courtney D DiNardoUniversity of Texas MD Anderson Cancer Center
Robert H CollinsUniversity of Texas Southwestern Medical Center
Justin M WattsUniversity of Miami, Sylvester Comprehensive Cancer Center
  • 1 - 3

Datasets

Release 1.2